Casting doubt on the safety of "off-the-shelf" mesenchymal stem cells for cell therapy

Molecular Therapy

Volumn 17, Issue 2, 2009, Pages 216-218

  Rameshwar, Pranela ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; RETROVIRUS VECTOR; ANTIBODY;

ALLOGENEIC STEM CELL TRANSPLANTATION; ANEMIA; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CYTOKINE RELEASE; GRAFT VERSUS HOST REACTION; HEART INFARCTION; HEMATOCRIT; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; MESENCHYMAL STEM CELL; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NOTE; PATIENT SAFETY; STEM CELL GENE THERAPY; TREATMENT RESPONSE; TUMOR GROWTH; UPREGULATION; VIRAL GENE DELIVERY SYSTEM; ALLOTRANSPLANTATION; ANIMAL; BAGG ALBINO MOUSE; BIOLOGICAL THERAPY; C57BL MOUSE; CELL LINE; CYTOLOGY; FEMALE; IMMUNOLOGY; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; METHODOLOGY; MOUSE; MOUSE MUTANT; PHYSIOLOGY; STROMA CELL;

ANEMIA; ANIMALS; ANTIBODIES; CELL LINE; ERYTHROPOIETIN; FEMALE; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; STROMAL CELLS; TISSUE THERAPY; TRANSPLANTATION, HOMOLOGOUS;

EID: 63649106995     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2008.296     Document Type: Note

References (16)

1. Wang, H and Chen, X (2008). Imaging mesenchymal stem cell migration and the implications for stem cell-based cancer therapies. Future Oncol 4: 623-628.
2. Gottfried, ON and Dailey, AT (2008). Mesenchymal stem cell and gene therapies for spinal fusion. Neurosurgery 63: 380-391.
3. Campeau, PM, Rafei, M, François, M, Birman, E, Forner, K-A and Galipeau, J (2009). Mesenchymal stromal cells engineered to express erythropoietin induce anti-erythropoietin antibodies and anemia in allorecipients. Mol Ther 16: 369-372.
4. Chen, J and Chopp, M (2006). Neurorestorative treatment of stroke: Cell and pharmacological approaches. NeuroRX 3: 466-473.
5. Chopp, M, Li, Y and Zhang, J (2008). Plasticity and remodeling of brain. J Neurol Sci 265: 97-101.
6. Casiraghi, F, Azzollini, N, Cassis, P, Imberti, B, Morigi, M, Cugini, D et al. (2008). Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. J Immunol 181: 3933-3946.
7. Potian, JA, Aviv, H, Ponzio, NM, Harrison, JS and Rameshwar, P (2003). Veto-like activity of mesenchymal stem cells: Functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol 171: 3426-3434.
8. Glennie, S, Soeiro, I, Dyson, PJ, Lam, EWF and Dazzi, F (2005). Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 105: 2821-2827.
9. Gascon, P (2008). Safety update on erythropoiesis-stimulating agents: trials within and outside the accepted indications. Oncologist 13: 4-10.
10. Newland, AM and Black, CD (2008). Tumor progression associated with erythropoiesis-stimulating agents. Ann Pharmacother (in the press).
11. Flores-Figueroa, E, Montesinos, JJ, Flores-Guzmán, P, Gutierrez-Espindola, G, Arana-Trejo, RM, Castillo-Medina, S et al. (2008). Functional analysis of myelodysplastic syndromes-derived mesenchymal stem cells. Leukemia Res 32: 1407-1416.
12. Chan, JL, Tang, KC, Patel, AP, Bonilla, LM, Pierobon, N, Ponzio, NM et al. (2006). Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-γ. Blood 107: 4817-4824.
13. Stagg, J, Pommey, S, Eliopoulos, N and Galipeau, J (2006). Interferon-γ-stimulated marrow stromal cells: A new type of nonhematopoietic antigen-presenting cell. Blood 107: 2570-2577.
14. Young, NS, Scheinberg, P and Calado, RT (2008). Aplastic anemia. Curr Opin Hematol 15: 162-168.
15. Bacigalupo, A, Valle, M, Podestà, M, Pitto, A, Zocchi, E, De Flora, A et al. (2005). T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia. Exp Hematol 33: 819-827.
16. Prigozhina, TB, Khitrin, S, Elkin, G, Eizik, O, Morecki, S and Slavin, S (2008). Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation. Exp Hematol 36: 1370-1376.